News

Rafal Kaminski contributes an op-ed to Labiotech in which he presents an overview of the current treatment landscape for people living with epilepsy.

Initiated by the European Commission and funded by the Marie Sklodowska Curie Actions (MSCA), European Researchers' Night is the largest science outreach and research event in Europe.

Jacopo Andreose advocates for increased European investment in Mental Health, highlighting its societal and economic benefits in an Op-Ed for Euroactiv.

Launched by the WHO in 2019, World Patient Safety Day is observed annually on 17th September in recognition of patient safety as a large and growing public healthcare challenge.

Organised by the International League Against Epilepsy (ILAE) and held biennially between 7th and 11th September, Angelini Pharma is proud to announce its participation in the 15th EEC.

Brain health and sex and gender differences represent a crucial and innovative area of study in modern medicine.

World Brain Day is a global initiative that occurs annually on 22nd July and is dedicated to raising awareness of the importance of Brain Health and advancing education on neurological diseases.

Identifying new options to increase adherence is vital to the epilepsy community.

Angelini Pharma is proud to announce its participation in the European Academy of Neurology Congress 2024 (EAN), representing Europe’s largest forum for Neurology.

"Heat therapy, a practice that has stood the test of time, offers practical benefits for a variety of musculoskeletal conditions, making it a valuable tool in our field", Prof. Jürgen Freiwald.